Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study
Abstract Background Pulmonary hypertension (PH) is a complication of chronic kidney disease (CKD) that contributes to mortality. Sclerostin, a SOST gene product that reduces osteoblastic bone formation by inhibiting Wnt/β-catenin signaling, is involved in arterial stiffness and CKD-bone mineral dise...
Main Authors: | Jonghyun Lee, Dong-Hyuk Cho, Hyeon-Jin Min, Young-Bin Son, Tae Bum Kim, Se Won Oh, Myung-Gyu Kim, Won Yong Cho, Sang-Kyung Jo, Jihyun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-024-02871-8 |
Similar Items
-
Intestinal microbiota and kidney diseases
by: Myung-Gyu Kim, et al.
Published: (2021-09-01) -
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis
by: Carlo Garofalo, et al.
Published: (2023-03-01) -
Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study
by: Te-Hui Kuo, et al.
Published: (2019-07-01) -
Tackling Dialysis Burden around the World: A Global Challenge
by: Philip Kam-Tao Li, et al.
Published: (2021-04-01) -
Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy
by: Liliana Simões-Silva, et al.
Published: (2020-01-01)